摘要
综述国际最近20年关于肾癌生长速度的研究,发现大部分临床上偶然发现的早期肾癌生长缓慢,且发生转移的几率也低。这对部分不适合手术的肾癌进行保守治疗提供了临床指导及理论依据。
出处
《现代泌尿外科杂志》
CAS
2012年第4期425-427,共3页
Journal of Modern Urology
参考文献17
-
1KASSOUF W, AG APRIKIAN, M LAPLANTE, et al. Natu- ral history of renal masses followed expectantly [J]. J Urol, 2004, 171(1):111-113.
-
2WEHLE MJ, DD THIEL, SP PETROU, et al. Conservative management of incidental contrast enhancing renal masses as safe alternative to invasive therapy[J].Urology, 2004, 64(1): 49-52.
-
3KATO M, T SUZUKI, Y SUZUKI, et al. Natural history of small renal cell carcinoma : evaluation of growth rate, histological grade, cell proliferation and apoptosis[J]. J Urol, 2004, 172(3):863-866.
-
4PUNNEN S, HAIDER MA, LOCKWOOD G, et al. Variability in size measurement of renal masses smaller than 4 cm on corn puterized tomography [ J ]. J Urol, 2006, 176 ( 6 Pt 1 ) :2386-2390.
-
5GILLETT MD, JC CHEVILI.E, RJ KARNES, et al. Compari son of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses[J]. J Urol, 2005, 173(6) : 1893-1896.
-
6FRANK I, ML BI.UTE, JC CHEVILLE, et al. Solid renal tumors:an analysis of pathological features related to tumor size [J]. J Urol, 2003, 170(6 Pt 1):2217-2220.
-
7LAMB GW, EJ BROMWICH, P VASEY, et al. Management of renal masses in patients medically unsuitable for nephrectomy- natural history, complications, and outcome[J]. Urology, 2004, 64(5) :909-913.
-
8FUJIMOTO N, A SUGITA, Y TERASAWA, et al. Observa tions on the growth rate of renal cell carcinoma[J]. Int J Urol, 1995, 2(2):71-76.
-
9BOSNIAK MA, BA BIRNBAUM, GA KRINSKY, et al. Small renal parenchymal neoplasms: furtber observations on growth [J]. Radiology, 1995, 197(3):589-597.
-
10LEE JY, CK KIM, D CHOI, et al. Volume doubling time and growth rate of renal cell carcinoma determined by helical CT: a single-institution experience[J]. Eur Radiol, 2008, 18(4): 731-737.
同被引文献34
-
1CHUNG JH, LEE SW, LEE KS, et al. Safety of en bloc ligation of the renal hilum during laparoscopic radical nephrectomy for renal cell carcinoma: a randomized controlled trial[J]. J Laparo- endosc Adv Surg Tech A, 2013,23(6) :489-494.
-
2NADU A, GOLDBERG H, LUBIN M, et ak Laparoscopic par- tial nephrectomy (LPN) for totally intrarenal tumours[J]. BJU Int,2013,112(2) : E82-86.
-
3Harshman LC,Yu RJ,Allen GI,et al. Surgical outcomes and compli - cations associated with presurglcal tyrosine kinase inhibition for advanced renal cell carcinoma (RCC) [J]. Urol. Oncol, 2013,31: 379-385.18.
-
4Guo J, Huang YR,Zhang X,et al.Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy:an open-label phase lb study[J]. BMC Cancer,2013,13:136.
-
5National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: kidney cancer.2013.V1.May 12th,2012.
-
6Procopio G, Bellmunt J, Dutcher J, et al. Sorafenib tolerability in elderly patients with advanced renal cell carcinoma:results from a large pooled analysis[J].Br J Cancer,2013,108:311-318.
-
7Bergmann L,Goebell PJ,Kube U,et al.Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy: results of an interim analysis of a non-interventional study[J]. Oncology,2013,36:95-100.
-
8吴义生,吴长利,陈剑秋.肾癌伴腔静脉癌栓的手术治疗[J].中国肿瘤临床,2010,37(14):817-819. 被引量:1
-
9王权,周文生.小肾癌的治疗策略[J].中华全科医学,2010,8(12):1590-1592. 被引量:5
-
10张志强,于德新,方卫华,江山,施浩强,廖贵益,赵磊.年龄和环境对肾细胞癌临床病理特征的影响[J].实用癌症杂志,2010,25(6):642-645. 被引量:1
二级引证文献5
-
1李伟中.腹腔镜肾癌根治术与开放肾癌根治术的临床疗效对比[J].中国继续医学教育,2015,7(7):91-92. 被引量:1
-
2李震.后腹腔镜下肾部分切除术治疗肾肿瘤的疗效及安全性评价[J].临床医学研究与实践,2017,2(29):73-74. 被引量:1
-
3姜熙,仲冰.腹腔镜、后腹腔镜在不同肾肿瘤直径根治术中的优缺点比较[J].医学临床研究,2017,34(12):2386-2388. 被引量:2
-
4宋晓春.肾癌误诊1例报告[J].河南医学高等专科学校学报,2019,31(2):183-184.
-
5徐虎,袁建林.后腹腔镜肾癌根治术治疗90例肾癌的临床观察[J].中华肿瘤防治杂志,2016,23(S1):176-177. 被引量:6
-
1蒋荣斌.肿瘤标志物对临床的指导作用[J].现代诊断与治疗,2013,24(1):188-189.
-
2张高明,侯文权,李志沭,胡礼仪.鼻咽癌患者HIF-1α、VEGF-C、COX-2和IL-10表达研究[J].检验医学与临床,2010,7(24):2728-2730. 被引量:2
-
3李今,张红丽.ER、PR在乳腺癌中的表达及临床意义[J].现代肿瘤医学,2009,17(10):1877-1878. 被引量:2
-
4李忠海,王英磊,曹现祥,曹先德,赵占魁,孟琳,肖琳,范成娟.多因素分析前列腺癌无进展生存期及其临床指导价值探讨[J].临床医学研究与实践,2017,2(3):6-7. 被引量:2
-
5肖鸿霖.早期乳腺癌保乳手术临床指导[J].医学信息,2013(2):177-177.
-
6王建飞,韩晓红,石远凯.kras基因突变检测对结直肠癌靶向治疗的临床指导意义[J].中华检验医学杂志,2012,35(3):286-288. 被引量:7
-
7魏毅玲,雷大鹏,潘新良,栾信庸,于家华.eIF4E与FHIT在下咽癌中的表达[J].山东大学基础医学院学报,2004,18(6):357-358. 被引量:1
-
8袁莉,赵辉,李琳,王卫华.P-AKT在非小细胞肺癌中的表达及意义[J].泰山医学院学报,2013,34(2):94-97.
-
9赖瑾瑜.超声双重造影与直肠腔内灌注超声造影对直肠癌分型的应用价值比较[J].现代诊断与治疗,2016,27(14):2690-2691. 被引量:1
-
10陈晓军,杨磊,师大雷,王政.侵袭性胸腺瘤的 Axin 和β-catenin 表达研究[J].中国实用医刊,2016,43(4):3-5.